Successful Intra-Arterial Thrombolysis in Basilar Thrombosis Secondary to Infectious Endocarditis

2003 ◽  
Vol 16 (3) ◽  
pp. 295-297 ◽  
Author(s):  
Massimiliano Siccoli ◽  
David Benninger ◽  
Bernhard Schuknecht ◽  
Rolf Jenni ◽  
Anton Valavanis ◽  
...  
Keyword(s):  
Infectious Endocarditis ◽  
Basilar Thrombosis ◽  
Arterial Thrombolysis

scholarly journals Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis

Stroke ◽  
2006 ◽  
Vol 37 (9) ◽  
pp. 2436-2437 ◽  
Author(s):  
Geoffrey A. Donnan ◽  
Stephen M. Davis ◽  
Peter D. Schellinger ◽  
Werner Hacke
Keyword(s):  
Basilar Thrombosis ◽  
Arterial Thrombolysis

Peripheral Arterial Thrombolysis by Modified Pulse-Spray Method

1994 ◽  
Vol 30 (5) ◽  
pp. 835
Author(s):  
Ki Nam Lee ◽  
Sun Seob Choi ◽  
Yung Il Lee ◽  
Byeong Ho Park ◽  
Jae Ik Kim ◽  
...  
Keyword(s):  
Spray Method ◽  
Peripheral Arterial ◽  
Arterial Thrombolysis

scholarly journals Infectious Endocarditis, Vasculitis, and Glomerulonephritis

1999 ◽  
Vol 28 (6) ◽  
pp. 1342-1343 ◽  
Author(s):  
Julio Collazos ◽  
Fernando Díaz ◽  
Jose Mayo ◽  
Eduardo Martínez
Keyword(s):  
Infectious Endocarditis

scholarly journals DIASTOLIC MITRAL REGURGITATION CAUSED BY AORTIC INSUFFICIENCY IN A PATIENT WITH INFECTIOUS ENDOCARDITIS

2021 ◽  
Vol 77 (18) ◽  
pp. 2899
Author(s):  
Vrinda Vyas ◽  
Sean Byrnes ◽  
Harneet Bhatti ◽  
Muhammad B. Malik ◽  
Debanik Chaudhuri ◽  
...  
Keyword(s):  
Mitral Regurgitation ◽  
Aortic Insufficiency ◽  
Infectious Endocarditis

Increased Rates of Hemorrhages after Endovascular Stroke Treatment with Emergency Carotid Artery Stenting and Dual Antiplatelet Therapy

2021 ◽  
pp. 1-9
Author(s):  
Felix Hadler ◽  
Raveena Singh ◽  
Martin Wiesmann ◽  
Arno Reich ◽  
Omid Nikoubashman
Keyword(s):  
Risk Factors ◽  
Carotid Artery ◽  
Antiplatelet Therapy ◽  
Carotid Artery Stenting ◽  
Dual Antiplatelet Therapy ◽  
Stroke Treatment ◽  
Systemic Thrombolysis ◽  
Stroke Registry ◽  
Increased Risk ◽  
Arterial Thrombolysis

<b><i>Background:</i></b> While endovascular stroke treatment (EST) of large vessel occlusions in acute ischemic stroke (AIS) is proven to be safe and effective, there are subgroups of patients with increased rates of hemorrhages. Our goal was to identify risk factors for intracerebral hemorrhage and to assess whether acute carotid artery stenting (CAS) was associated with increased bleeding rates. <b><i>Methods:</i></b> We performed a retrospective analysis of our monocentric prospective stroke registry in the period from May 2010 to May 2018 and compared AIS patients receiving EST with (<i>n</i> = 73) versus without acute CAS (<i>n</i> = 548). Patients with intracranial stents, intra-arterial thrombolysis, or dissection of the carotid artery were excluded. <b><i>Results:</i></b> Parenchymal hemorrhage rates (PH2 according to the ECASS classification) and symptomatic hemorrhage (sICH) rates were increased in EST patients receiving CAS with odds being 6.3 (PH2) and 6.5 (sICH) times higher (PH2 17.8 vs. 3.3%, <i>p</i> &#x3c; 0.001 and sICH: 16.4 vs. 2.9%, <i>p</i> &#x3c; 0.001). Additional systemic thrombolysis with rtPA (IVRTPA) was no risk factor for cerebral hemorrhage (<i>p</i> = 0.213). <b><i>Conclusion:</i></b> AIS patients receiving EST with acute CAS and consecutive tirofiban or dual antiplatelet therapy suffered from an increased risk of relevant secondary intracranial bleeding. After adjusting for confounders, tirofiban and dual antiplatelet therapy were associated with higher bleeding rates.

Sign in / Sign up

Export Citation Format

Share Document